Ifosfamide (CAS 3778-73-2) Market Report

China Ifosfamide (CAS 3778-73-2) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 13, 2023
  • PAGES：143
  • REPORT CODE：GMM1851492
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Ifosfamide is positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. It is a synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication. This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. Ifosfamide is used in the treatment of several forms of cancer including lymphomas, sarcoma and advanced forms of solid organ cancer such as breast, testicular, ovarian, gastric and lung cancer. Ifosfamide therapy is associated with minor transient serum enzyme elevations and has been linked to cases of acute liver injury, including acute cholestatic hepatitis and veno-occlusive disease.

    This report elaborates on the current development of the Ifosfamide (CAS 3778-73-2) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • APP

    • Alkem

    • Nanjing Cuccess Pharmaceutical Co Ltd

    • Baxter

    • Hengrui

    • Delta Farma

    • Stada

    • Laboratorio LKM

    • Laboratorio Kampar

    • Sanfer

    • Pisa

    • Zydus

    • Teva

    • Korea United Pharma

    By Type:

    • API（Active Pharmaceutical Ingredients）

    • Preparation

    By Application:

    • Sarcoma

    • Solid organ cancer

    • Lymphomas

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Ifosfamide (CAS 3778-73-2) Market Overview 2018-2029

    • 1.1 China Ifosfamide (CAS 3778-73-2) Industry Development Overview

    • 1.2 China Ifosfamide (CAS 3778-73-2) Industry Development History

    • 1.3 China Ifosfamide (CAS 3778-73-2) Industry Market Size (2018-2029)

    • 1.4 China Ifosfamide (CAS 3778-73-2) Market Analysis by Type from Production Side

      • 1.4.1 China Ifosfamide (CAS 3778-73-2) Production Volume, Production Value and Growth Rate of API（Active Pharmaceutical Ingredients） (2018-2029)

      • 1.4.2 China Ifosfamide (CAS 3778-73-2) Production Volume, Production Value and Growth Rate of Preparation (2018-2029)

    • 1.5 China Ifosfamide (CAS 3778-73-2) Market Analysis by Application from Consumption End

      • 1.5.1 China Ifosfamide (CAS 3778-73-2) Sales Volume, Sales Value and Growth Rate of Sarcoma (2018-2029)

      • 1.5.2 China Ifosfamide (CAS 3778-73-2) Sales Volume, Sales Value and Growth Rate of Solid organ cancer (2018-2029)

      • 1.5.3 China Ifosfamide (CAS 3778-73-2) Sales Volume, Sales Value and Growth Rate of Lymphomas (2018-2029)

    • 1.6 China Ifosfamide (CAS 3778-73-2) Market Analysis by Region

      • 1.6.1 North China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Ifosfamide (CAS 3778-73-2) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Ifosfamide (CAS 3778-73-2) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Ifosfamide (CAS 3778-73-2) Market Status and Competition Analysis in 2023

      • 2.2.3 China Ifosfamide (CAS 3778-73-2) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Ifosfamide (CAS 3778-73-2) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Ifosfamide (CAS 3778-73-2) Industry Development

    Chapter 3 Ifosfamide (CAS 3778-73-2)Industry Chain Analysis

    • 3.1 Ifosfamide (CAS 3778-73-2) Industry Chain

    • 3.2 Ifosfamide (CAS 3778-73-2) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Ifosfamide (CAS 3778-73-2) Market

    • 3.3 Ifosfamide (CAS 3778-73-2) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Ifosfamide (CAS 3778-73-2) Market

    Chapter 4 China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 4.1 China Ifosfamide (CAS 3778-73-2) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Ifosfamide (CAS 3778-73-2) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Ifosfamide (CAS 3778-73-2) Production Volume and Growth Rate, by Type

      • 4.5.1 China Ifosfamide (CAS 3778-73-2) Production Volume and Growth Rate of API（Active Pharmaceutical Ingredients）

      • 4.5.2 China Ifosfamide (CAS 3778-73-2) Production Volume and Growth Rate of Preparation

    Chapter 5 China Ifosfamide (CAS 3778-73-2) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Ifosfamide (CAS 3778-73-2) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate, by Application

      • 5.5.1 China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate of Sarcoma

      • 5.5.2 China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate of Solid organ cancer

      • 5.5.3 China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate of Lymphomas

    Chapter 6 China Ifosfamide (CAS 3778-73-2) Market, by Region

    • 6.1 China Ifosfamide (CAS 3778-73-2) Production Volume and Production Value, by Region

    • 6.2 China Ifosfamide (CAS 3778-73-2) Sales Volume and Sales Value, by Region

    Chapter 7 North China Ifosfamide (CAS 3778-73-2) Market Analysis

    • 7.1 North China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 7.2 North China Ifosfamide (CAS 3778-73-2) Market, by Application

    Chapter 8 Central China Ifosfamide (CAS 3778-73-2) Market Analysis

    • 8.1 Central China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 8.2 Central China Ifosfamide (CAS 3778-73-2) Market, by Application

    Chapter 9 South China Ifosfamide (CAS 3778-73-2) Market Analysis

    • 9.1 South China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 9.2 South China Ifosfamide (CAS 3778-73-2) Market, by Application

    Chapter 10 East China Ifosfamide (CAS 3778-73-2) Market Analysis

    • 10.1 East China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 10.2 East China Ifosfamide (CAS 3778-73-2) Market, by Application

    Chapter 11 Northeast China Ifosfamide (CAS 3778-73-2) Market Analysis

    • 11.1 Northeast China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 11.2 Northeast China Ifosfamide (CAS 3778-73-2) Market, by Application

    Chapter 12 Southwest China Ifosfamide (CAS 3778-73-2) Market Analysis

    • 12.1 Southwest China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 12.2 Southwest China Ifosfamide (CAS 3778-73-2) Market, by Application

    Chapter 13 Northwest China Ifosfamide (CAS 3778-73-2) Market Analysis

    • 13.1 Northwest China Ifosfamide (CAS 3778-73-2) Market, by Type

    • 13.2 Northwest China Ifosfamide (CAS 3778-73-2) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 APP

        • 14.1.1 APP Company Profile

        • 14.1.2 APP Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Alkem

        • 14.2.1 Alkem Company Profile

        • 14.2.2 Alkem Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Nanjing Cuccess Pharmaceutical Co Ltd

        • 14.3.1 Nanjing Cuccess Pharmaceutical Co Ltd Company Profile

        • 14.3.2 Nanjing Cuccess Pharmaceutical Co Ltd Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Baxter

        • 14.4.1 Baxter Company Profile

        • 14.4.2 Baxter Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hengrui

        • 14.5.1 Hengrui Company Profile

        • 14.5.2 Hengrui Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Delta Farma

        • 14.6.1 Delta Farma Company Profile

        • 14.6.2 Delta Farma Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Stada

        • 14.7.1 Stada Company Profile

        • 14.7.2 Stada Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Laboratorio LKM

        • 14.8.1 Laboratorio LKM Company Profile

        • 14.8.2 Laboratorio LKM Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Laboratorio Kampar

        • 14.9.1 Laboratorio Kampar Company Profile

        • 14.9.2 Laboratorio Kampar Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Sanfer

        • 14.10.1 Sanfer Company Profile

        • 14.10.2 Sanfer Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Pisa

        • 14.11.1 Pisa Company Profile

        • 14.11.2 Pisa Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Zydus

        • 14.12.1 Zydus Company Profile

        • 14.12.2 Zydus Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Teva

        • 14.13.1 Teva Company Profile

        • 14.13.2 Teva Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Korea United Pharma

        • 14.14.1 Korea United Pharma Company Profile

        • 14.14.2 Korea United Pharma Ifosfamide (CAS 3778-73-2) Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Ifosfamide (CAS 3778-73-2) Industry Research Conclusions

    • 15.2 Ifosfamide (CAS 3778-73-2) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Ifosfamide (CAS 3778-73-2) Industry Market Size (2018-2029)

    • Figure China Ifosfamide (CAS 3778-73-2) Production Volume, Production Value and Growth Rate of API（Active Pharmaceutical Ingredients） (2018-2029)

    • Figure China Ifosfamide (CAS 3778-73-2) Production Volume, Production Value and Growth Rate of Preparation (2018-2029)

    • Figure China Ifosfamide (CAS 3778-73-2) Sales Volume, Sales Value and Growth Rate of Sarcoma (2018-2029)

    • Figure China Ifosfamide (CAS 3778-73-2) Sales Volume, Sales Value and Growth Rate of Solid organ cancer (2018-2029)

    • Figure China Ifosfamide (CAS 3778-73-2) Sales Volume, Sales Value and Growth Rate of Lymphomas (2018-2029)

    • Figure North China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    • Figure Central China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    • Figure South China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    • Figure East China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate from 2018-2029

    • Figure Ifosfamide (CAS 3778-73-2) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Ifosfamide (CAS 3778-73-2) Market Share by Type in 2018

    • Figure China Ifosfamide (CAS 3778-73-2) Market Share by Type in 2023

    • Figure China Ifosfamide (CAS 3778-73-2) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Production Volume and Growth Rate of API（Active Pharmaceutical Ingredients） (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Production Volume and Growth Rate of Preparation (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Market Share by Application in 2018

    • Figure China Ifosfamide (CAS 3778-73-2) Market Share by Application in 2023

    • Figure China Ifosfamide (CAS 3778-73-2) Total Market Size and Growth Rate from Consumption End

    • Figure China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate of Sarcoma (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate of Solid organ cancer (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Market Size and Growth Rate of Lymphomas (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Production Volume by Region (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Production Volume Share by Region (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Production Volume Share by Region (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Production Value by Region (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Production Value Share by Region (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Production Value Share by Region (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Sales Volume by Region (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Region (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Region (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Sales Value by Region (2018-2023)

    • Table China Ifosfamide (CAS 3778-73-2) Sales Value Share by Region (2018-2023)

    • Figure China Ifosfamide (CAS 3778-73-2) Sales Value Share by Region (2018-2023)

    • Table North China Ifosfamide (CAS 3778-73-2) Production Volume by Type (2018-2023)

    • Table North China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Figure North China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Table North China Ifosfamide (CAS 3778-73-2) Sales Volume by Application (2018-2023)

    • Table North China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Figure North China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Table Central China Ifosfamide (CAS 3778-73-2) Production Volume by Type (2018-2023)

    • Table Central China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Figure Central China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Table Central China Ifosfamide (CAS 3778-73-2) Sales Volume by Application (2018-2023)

    • Table Central China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Figure Central China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Table South China Ifosfamide (CAS 3778-73-2) Production Volume by Type (2018-2023)

    • Table South China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Figure South China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Table South China Ifosfamide (CAS 3778-73-2) Sales Volume by Application (2018-2023)

    • Table South China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Figure South China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Table East China Ifosfamide (CAS 3778-73-2) Production Volume by Type (2018-2023)

    • Table East China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Figure East China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Table East China Ifosfamide (CAS 3778-73-2) Sales Volume by Application (2018-2023)

    • Table East China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Figure East China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Ifosfamide (CAS 3778-73-2) Production Volume by Type (2018-2023)

    • Table Northeast China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Table Northeast China Ifosfamide (CAS 3778-73-2) Sales Volume by Application (2018-2023)

    • Table Northeast China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Ifosfamide (CAS 3778-73-2) Production Volume by Type (2018-2023)

    • Table Southwest China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Table Southwest China Ifosfamide (CAS 3778-73-2) Sales Volume by Application (2018-2023)

    • Table Southwest China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Ifosfamide (CAS 3778-73-2) Production Volume by Type (2018-2023)

    • Table Northwest China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Ifosfamide (CAS 3778-73-2) Production Volume Share by Type (2018-2023)

    • Table Northwest China Ifosfamide (CAS 3778-73-2) Sales Volume by Application (2018-2023)

    • Table Northwest China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Ifosfamide (CAS 3778-73-2) Sales Volume Share by Application (2018-2023)

    • Table APP Company Profile

    • Table APP Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Alkem Company Profile

    • Table Alkem Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Nanjing Cuccess Pharmaceutical Co Ltd Company Profile

    • Table Nanjing Cuccess Pharmaceutical Co Ltd Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Hengrui Company Profile

    • Table Hengrui Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Delta Farma Company Profile

    • Table Delta Farma Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Stada Company Profile

    • Table Stada Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Laboratorio LKM Company Profile

    • Table Laboratorio LKM Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Laboratorio Kampar Company Profile

    • Table Laboratorio Kampar Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Sanfer Company Profile

    • Table Sanfer Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Pisa Company Profile

    • Table Pisa Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Zydus Company Profile

    • Table Zydus Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)

    • Table Korea United Pharma Company Profile

    • Table Korea United Pharma Ifosfamide (CAS 3778-73-2) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US